Roni T Falk

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Roni T Falk
    Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, 9609 Medical Center Drive, Bethesda, MD, 20852, USA
    Cancer Causes Control 27:1009-17. 2016
  2. pmc Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women
    Roni T Falk
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 24:1419-22. 2015
  3. pmc Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women
    Roni T Falk
    Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA
    Breast Cancer Res Treat 131:287-94. 2012
  4. pmc A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability
    Roni T Falk
    National Cancer Institute, 6120 Executive Boulevard, EPS 5137, Rockville, MD 20892 7234, USA
    Cancer Epidemiol Biomarkers Prev 17:3411-8. 2008
  5. pmc Measurement of sex steroid hormones in breast adipocytes: methods and implications
    Roni T Falk
    Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard S, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 17:1891-5. 2008
  6. pmc Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
    Sarah J Nyante
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Breast Cancer Res 13:R42. 2011
  7. pmc Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer
    Xiaohong R Yang
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH DHHS, 6120 Executive Blvd, Bethesda, MD USA
    Breast Cancer Res Treat 137:837-47. 2013
  8. doi request reprint Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort
    Cher M Dallal
    Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, 20742, USA
    Horm Cancer 7:49-64. 2016
  9. pmc Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry
    Barbara J Fuhrman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 23:2649-57. 2014
  10. pmc Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Epidemiol Biomarkers Prev 19:292-300. 2010

Detail Information

Publications42

  1. pmc A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Roni T Falk
    Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, 9609 Medical Center Drive, Bethesda, MD, 20852, USA
    Cancer Causes Control 27:1009-17. 2016
    ..Pro-angiogenic factors are positively associated with breast tumor staging and poorer prognosis, but their role in the etiology of breast cancer has not been assessed...
  2. pmc Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women
    Roni T Falk
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 24:1419-22. 2015
    ..These few prior studies focused on parent estrogens; none evaluated effects of estrogen metabolism in postmenopausal women...
  3. pmc Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women
    Roni T Falk
    Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA
    Breast Cancer Res Treat 131:287-94. 2012
    ..Measurement of sex hormones in serum and in the microenvironment may help in understanding the hormonal etiology of breast cancer, suggest methods for prevention, and have value in gauging treatment response and prognosis...
  4. pmc A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability
    Roni T Falk
    National Cancer Institute, 6120 Executive Boulevard, EPS 5137, Rockville, MD 20892 7234, USA
    Cancer Epidemiol Biomarkers Prev 17:3411-8. 2008
    ....
  5. pmc Measurement of sex steroid hormones in breast adipocytes: methods and implications
    Roni T Falk
    Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard S, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 17:1891-5. 2008
    ....
  6. pmc Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
    Sarah J Nyante
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Breast Cancer Res 13:R42. 2011
    ..Thus, we examined the relationship between single nucleotide polymorphisms (SNPs) in PRL and PRLR, serum prolactin levels and breast cancer risk in a population-based case-control study...
  7. pmc Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer
    Xiaohong R Yang
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH DHHS, 6120 Executive Blvd, Bethesda, MD USA
    Breast Cancer Res Treat 137:837-47. 2013
    ..Analyses of mapped TDLUs may provide information about the sequence of molecular changes occurring in breast carcinogenesis...
  8. doi request reprint Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort
    Cher M Dallal
    Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, 20742, USA
    Horm Cancer 7:49-64. 2016
    ..Estrogen metabolism may be important in endometrial carcinogenesis, particularly with less extensive methylation of 2- or 4-pathway catechols associated with elevated endometrial cancer risk...
  9. pmc Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry
    Barbara J Fuhrman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 23:2649-57. 2014
    ....
  10. pmc Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Epidemiol Biomarkers Prev 19:292-300. 2010
    ..2% and < or =17.8%). Comparison with the LC-MS/MS method suggests that the widely used RIA and ELISA estrogen metabolite measures may be problematic, especially at low estrogen metabolite levels characteristic of postmenopausal women...
  11. pmc Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women
    Linda Morris Brown
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Breast Cancer Res Treat 120:203-10. 2010
    ....
  12. pmc Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 25:1081-9. 2016
    ..Although endometrial cancer is clearly influenced by hormonal factors, few epidemiologic studies have investigated the role of endogenous estrogens or especially estrogen metabolites...
  13. pmc Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy
    Hannah Oh
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Horm Cancer 7:305-315. 2016
    ..Our data suggest that higher levels of serum EMs are generally associated with lower levels of TDLU involution...
  14. pmc Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism
    Cher M Dallal
    1Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD 2Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 3Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 4Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 5Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 6M Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, POLAND 7Division of Breast Cancer Research, Division of Genetics and Epidemiology and Breakthrough Breast Cancer Centre, The Institute of Cancer Research, London, UNITED KINGDOM 8Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC Frederick, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD and 9C2N Diagnostics, Saint Louis, MO
    Med Sci Sports Exerc 48:439-48. 2016
    ....
  15. pmc Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers
    Xiaohong R Yang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Breast Cancer Res 14:R64. 2012
    ..Accordingly, we performed a masked microscopic assessment of TDLU involution in benign tissues associated with luminal A and CBP breast cancers diagnosed among women less than age 55 years...
  16. pmc Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies
    Barbara J Fuhrman
    Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 7246, USA
    Int J Biol Markers 25:185-94. 2010
    ....
  17. pmc Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women
    Hannah P Yang
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Epidemiol 21:466-71. 2011
    ..Assessing the relationship of hormone concentration to total mass varies by body mass index (BMI) is etiologically important because obesity is related to hormone metabolism and cancer risk...
  18. ncbi request reprint Urinary estrogen metabolites and their ratio among Asian American women
    Roni T Falk
    Environmental Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, MSC 7234, Suite 7070, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 14:221-6. 2005
    ..Our study suggests that the ratio of 2-OHE(1):16alpha-OHE(1) may be a marker for lifestyle influences on estrogen metabolism associated with westernization...
  19. pmc Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results
    Louise A Brinton
    Affiliations of authors Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Lab, MBC, RTF, JHL Section on Environment and Radiation, International Agency for Research on Cancer, Lyon, France VM Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada KCJ Department of Oncology, Lund University, Lund, Sweden HO Department of Preventive Medicine, University of Southern California, Los Angeles, CA JTC, BEH, MCP, GU Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK RC, AJS Epidemiology Research Program, American Cancer Society, Atlanta, GA SMG, MMG Department of Medicine JMG, Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, Gynecology and Reproductive Biology KBM, and Divisions of Preventive Medicine and Aging HDS, Brigham and Women s Hospital, Boston, MA MAVERIC, VA Boston Healthcare System, Boston, MA JMG Department of Surgery, Boston University School of Medicine
    J Natl Cancer Inst 106:djt465. 2014
    ..The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors...
  20. pmc Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland
    Britton Trabert
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7E 228, Bethesda, MD, 20892 9774, USA
    Cancer Causes Control 25:1587-93. 2014
    ....
  21. ncbi request reprint Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry
    Ann W Hsing
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, EPS 5024, MSC 7234, 6120 Executive Boulevard, Bethesda, MD 20852 7234, USA
    Cancer Epidemiol Biomarkers Prev 16:1004-8. 2007
    ....
  22. pmc Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease
    HISANI N HORNE
    Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Rm 7 E108, Bethesda, MD, 20892 9774, USA
    Breast Cancer Res 18:24. 2016
    ....
  23. pmc Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk
    Louise A Brinton
    Louise A Brinton, Shannon N Wood, Roni T Falk, and Michael B Cook, National Cancer Institute, Bethesda Dominick Parisi, Information Management Services, Rockville, MD Tim J Key, University of Oxford, Oxford Elio Riboli, Imperial College School of Public Health, London, United Kingdom Laurence N Kolonel, University of Hawaii, Honolulu, HI Karin B Michels, Harvard Medical School and Harvard School of Public Health Karin B Michels and Howard D Sesso, Brigham and Women s Hospital, Boston, MA Giske Ursin, University of Oslo Giske Ursin and Elisabete Weiderpass, Cancer Registry of Norway, Oslo University of Tromsø Arctic University of Norway, Tromsø, Norway Karolinska Institutet, Stockholm, Sweden and Samfundet Folkhalsan, Helsinki, Finland Giske Ursin, University of Southern California, Los Angeles Stephen K Van Den Eeden and Laurel A Habel, Kaiser Permanente Northern California, Oakland, CA Chantal Guillemette, Patrick Caron, and Véronique Turcotte, Engineering Department
    J Clin Oncol 33:2041-50. 2015
    ..Although previous studies have implicated a variety of hormone-related risk factors in the etiology of male breast cancers, no previous studies have examined the effects of endogenous hormones...
  24. ncbi request reprint Serum sex hormones and breast cancer risk factors in postmenopausal women
    Charisee A Lamar
    Extramural Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland 20892, USA
    Cancer Epidemiol Biomarkers Prev 12:380-3. 2003
    ..Although BMI and parity could potentially modify breast cancer risk through hormonal mechanisms, age-related increases in breast cancer incidence do not appear to be mediated through changes in serum levels of the hormones evaluated...
  25. ncbi request reprint Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis
    Mark E Sherman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Int J Cancer 121:1079-85. 2007
    ..07) for low PR and HER2 expression vs. OR = 1.78 (95% CI = 1.25-2.55) for high expression (p-heterogeneity = 0.001). PR and HER2 levels in breast cancer vary by BMI, suggesting a heterogeneous etiology for tumors related to these markers...
  26. pmc Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study
    Britton Trabert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 25:648-56. 2016
    ..We evaluated whether serum estrogens and estrogen metabolite levels are associated with ovarian cancer risk among postmenopausal women in a nested case-control study in the Women's Health Initiative (WHI) Observational Study (OS)...
  27. pmc Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium
    Michael B Cook
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 24:520-31. 2015
    ..The etiology of male breast cancer is poorly understood, partly due to its relative rarity. Although tobacco and alcohol exposures are known carcinogens, their association with male breast cancer risk remains ill-defined...
  28. pmc Circulating sex hormones and terminal duct lobular unit involution of the normal breast
    Zeina G Khodr
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland
    Cancer Epidemiol Biomarkers Prev 23:2765-73. 2014
    ..We assessed whether circulating hormones, implicated in breast cancer risk, are associated with levels of TDLU involution using data from the Susan G. Komen Tissue Bank (KTB) at the Indiana University Simon Cancer Center (2009-2011)...
  29. pmc Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle
    Mahboobeh Safaeian
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Infect Dis 199:455-63. 2009
    ..The objective of this analysis was to describe patterns and determinants of cervical immunoglobulin A (IgA) and G (IgG) levels during the menstrual cycle...
  30. pmc Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women
    Joshua N Sampson
    Division of Cancer Epidemiology and Genetics, National Cancer Institute
    Cancer Res . 2016
    ..With appropriate validation, these findings suggest opportunities for breast cancer prevention by modifying individual estrogen metabolism profiles through either lifestyle alterations or chemopreventive strategies...
  31. pmc Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients
    Maeve Mullooly
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA
    Breast Cancer Res 19:8. 2017
    ..Accordingly, we examined relationships between CLS and sex-steroid hormones in breast adipose tissue and serum from postmenopausal breast cancer patients...
  32. pmc Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry
    Britton Trabert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA Electronic address
    J Steroid Biochem Mol Biol 155:56-62. 2016
    ..We developed a high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with two sample preparations to measure 11 androgens, including adrenal and gonadal androgenic precursors and their 5α-reduced metabolites...
  33. pmc Relationship of serum estrogens and metabolites with area and volume mammographic densities
    Gretchen L Gierach
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Horm Cancer 6:107-19. 2015
    ....
  34. pmc Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers
    Jennifer T Loud
    Clinical Genetics Branch CGB, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 6E536, Bethesda, MD, 20850 9772, USA
    Breast Cancer Res Treat 143:517-29. 2014
    ..If confirmed, future etiologic studies could utilize the more readily obtainable serum hormone levels as a reliable surrogate measure of exposure at the tissue level...
  35. ncbi request reprint Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women
    Roni T Falk
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, USA
    Breast Cancer Res Treat 98:157-65. 2006
    ..With the possible exception of leptin, our findings do not suggest that these markers explain the breast cancer protection provided by obesity in premenopausal women...
  36. pmc The impact of delayed blood centrifuging, choice of collection tube, and type of assay on 25-hydroxyvitamin D concentrations
    Chu Ling Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Boulevard, Mailstop 7238, Rockville, MD 20852, USA
    Cancer Causes Control 21:643-8. 2010
    ..01), but the difference was significant only after substantial centrifuging delays (96 h). Our study suggests no necessity for requiring immediate processing of blood samples after collection or for the choice of a tube type or assay...
  37. pmc Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study
    James J Goedert
    Division of Cancer Epidemiology and Genetics JJG, GJ, XH, Gy, RF, RTF, MHG, JS and Division of Cancer Prevention RF, National Cancer Institute, Bethesda, MD Cancer Research Technology Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD XX Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD JR Institute for Health Research, Kaiser Permanente Colorado, Denver, CO HSF
    J Natl Cancer Inst 107:. 2015
    ..This pilot study shows that postmenopausal women with breast cancer have altered composition and estrogen-independent low diversity of their gut microbiota. Whether these affect breast cancer risk and prognosis is unknown. ..
  38. pmc Immune status of patients with inherited bone marrow failure syndromes
    Neelam Giri
    Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland
    Am J Hematol 90:702-8. 2015
    ..05). Overall, immune function abnormalities were seen mainly in adult patients with FA, which likely reflects their disease-related progression, and in children with DC, which may be a feature of early-onset severe disease phenotype...
  39. pmc Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis
    Michael B Cook
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland Electronic address
    Clin Gastroenterol Hepatol 13:673-82. 2015
    ..Men develop BE and esophageal adenocarcinoma more frequently than women, yet little is known about the mechanisms of this difference. We assessed whether sex steroid hormones were associated with BE in a male population...
  40. pmc Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    D Michal Freedman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    Cancer Epidemiol Biomarkers Prev 17:889-94. 2008
    ....
  41. pmc Determinants and correlation of systemic and cervical concentrations of total IgA and IgG
    Mahboobeh Safaeian
    Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Suite 550, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 18:2672-6. 2009
    ..17 and 0.16, respectively). The lack of correlation between systemic and cervical total IgA and IgG suggests that systemic concentrations are not reflective of cervical levels...
  42. ncbi request reprint Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels
    Thomas R Fears
    Biostatistics Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Cancer Epidemiol Biomarkers Prev 11:785-9. 2002
    ..This reliability study design is, however, entirely appropriate for the typical case-control study which utilizes only one sample per subject...